Intracranial Support Catheter Market Report 2026

Intracranial Support Catheter Market Overview

• Intracranial Support Catheter market size has reached to $1.18 billion in 2025 • Expected to grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Surge In Neurological Disorders Driving The Growth Of The Market Due To Aging Population And Increasing Prevalence Of Conditions Including Dementia And Parkinson's Disease • Market Trend: Regulatory Approvals For Enhanced Intracranial Support Catheter Expands Market Access • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intracranial Support Catheter Market?

An intracranial support catheter is a specialized medical device used in neurovascular procedures to provide stability for navigating microcatheters and delivering treatment tools within the brain's blood vessels. It supports interventions such as thrombectomy and aneurysm repair by navigating complex intracranial anatomy, enhancing procedural success and safety. The main types of intracranial support catheters include ventricular catheters, subarachnoid catheters, intracerebral catheters, and drainage catheters. Ventricular catheters are flexible tubes inserted into the brain's ventricles to drain excess cerebrospinal fluid (CSF), commonly used in treating hydrocephalus and relieving intracranial pressure. These are distributed through direct sales, distributors and wholesalers, online sales platforms, and retail pharmacies for various applications, including neurovascular disorders, hydrocephalus treatment, traumatic brain injury, and others. It caters to various end users, including hospitals, specialty clinics, research institutions, and home care settings.

What Is The Intracranial Support Catheter Market Growth Forecast?

The intracranial support catheter market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive neurointerventions, rising investments in stroke care infrastructure, expansion of neurovascular device innovation, growing adoption of precision catheter systems, increasing focus on improved patient outcomes. Major trends in the forecast period include increasing use of support catheters in neurovascular procedures, rising adoption of advanced catheter navigation technologies, expansion of stroke and aneurysm treatment volumes, growing focus on device flexibility and trackability, enhanced emphasis on procedural safety.

Global Intracranial Support Catheter Market Segmentation

1) By Catheter Type: Ventricular Catheters, Subarachnoid Catheters, Intracerebral Catheters, Drainage Catheters 2) By Distribution Channel: Direct Sales, Distributors and Wholesalers 3) By Application: Neurovascular Disorders, Hydrocephalus Treatment, Traumatic Brain Injury, Other Neurological Applications 4) By End User: Hospitals, Specialty Clinics, Research Institutions, Neurocritical Care Units Subsegments: 1) By Ventricular Catheters: External Ventricular Drainage (EVD) Catheters, Ventriculoperitoneal (VP) Shunt Catheters, Ventriculoatrial (VA) Shunt Catheters 2) By Subarachnoid Catheters: Continuous Spinal Drainage Catheters, Lumbar Drainage Catheters 3) By Intracerebral Catheters: Intracerebral Pressure Monitoring Catheters, Intracerebral Drug Delivery Catheters 4) By Drainage Catheters: Cerebrospinal Fluid (CSF) Drainage Catheters, Hematoma Drainage Catheters

What Is The Driver Of The Intracranial Support Catheter Market?

The rising prevalence of neurological disorders is expected to propel the growth of the intracranial support catheter market going forward. Neurological disorders refer to diseases and conditions that affect the brain, spinal cord, and nerves, leading to problems with movement, sensation, cognition, or other bodily functions. The rising prevalence of neurological disorders can be largely attributed to the aging population, as older adults are more susceptible to conditions including dementia and Parkinson's disease. Intracranial support catheters are useful for neurological disorders as they provide a direct pathway for the delivery of medications or drainage of cerebrospinal fluid (CSF), helping to manage conditions such as hydrocephalus, brain injuries, or intracranial pressure imbalances. For instance, in May 2024, according to the Alzheimer's Society, a UK-based care and research charity, currently, 55 million people worldwide are living with dementia, a neurological disorder, and this number is expected to rise to 139 million by 2050. Therefore, the rising prevalence of neurological disorders is driving the growth of the intracranial support catheter industry.

Key Players In The Global Intracranial Support Catheter Market

Major companies operating in the intracranial support catheter market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Wallaby Medical Holding Inc., Terumo Corporation, Cook Medical Incorporated, Integer Holdings Corporation, Penumbra Inc., MicroPort Scientific Corporation, Imperative Care Inc., Phenox GmbH, Rapid Medical, Balt USA LLC, Acandis GmbH, Shanghai HeartCare Medical Technology Corporation, Zylox-TonBridge Medical Technology Co. Ltd., Mivi Neuroscience Inc., Integra LifeSciences Corporation, B. Braun Melsungen AG, Merit Medical Systems Inc., Teleflex Incorporated, Nipro Corporation

Global Intracranial Support Catheter Market Trends and Insights

Major companies operating in the intracranial support catheter market are focusing on obtaining regulatory approvals to expand their product portfolios and enhance market access. Regulatory approvals refer to the official authorization granted by regulatory bodies, such as the FDA, confirming that a medical device or product meets safety, efficacy, and quality standards for legal market use. For instance, in September 2023, MicroVention Inc., a US-based medical device company, announced that its SOFIA EX 5F 115 cm intracranial support catheter has received FDA 510(k) clearance. The SOFIA EX catheter, which stands for Soft TOrqueable catheter For Intracranial Access, is designed to provide enhanced support during neurovascular procedures, particularly for accessing the intracranial vasculature. This catheter is expected to improve clinical outcomes by providing better support and easier navigation during complex procedures, thereby enhancing the efficiency and safety of treatments for patients with neurovascular conditions. This clearance allows MicroVention to market the catheter for clinical use in various neurovascular interventions, further strengthening the company's position in the neurovascular market.

What Are Latest Mergers And Acquisitions In The Intracranial Support Catheter Market?

In March 2025, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, acquired SoniVie Ltd. for an undisclosed amount. With this acquisition, Boston Scientific aims to expand its interventional cardiology therapies portfolio by adding an ultrasound-based renal denervation therapy to treat hypertension, providing a minimally invasive alternative or adjunctive treatment to medications for blood pressure regulation. SoniVie Ltd. is an Israel-based medical device company specializing in innovative intravascular ultrasound (IVUS) technology for therapeutic applications.

Regional Outlook

North America was the largest region in the intracranial support catheter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intracranial Support Catheter Market?

The intracranial support catheter market consists of sales of distal access catheters, intermediate catheters, aspiration catheters, and steerable support catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.